NHS National Generics Pharmaceuticals Transition 2023_1
A Contract Award Notice
by NHS ENGLAND
- Source
- Contracts Finder
- Type
- Framework (Products)
- Duration
- 1.5 year
- Value
- £99M
- Sector
- HEALTH
- Published
- 24 May 2023
- Delivery
- 01 Aug 2023 to 31 Jan 2025
- Deadline
- 17 Feb 2023 13:00
Concepts
Location
1 buyer
- NHS England Runcorn
30 suppliers
- Ipca Laboratories Sunderland
- Drreddys Laboratories Milton
- Relonchem Widnes
- Milpharm South Ruislip
- Sandoz Camberley
- Teva Castleford
- Amarox Ely
- Accord Barnstable
- Strandhaven Ilford
- Tillomed Laboratories Luton
- Wockhardt Wrexham
- Neuraxpharm Cardiff
- Medac Pharma Stirling
- Syri Ruislip
- Sun Pharma Uxbridge
- Crescent Pharma Basingstoke
- Consilient Health Richmond upon Thames
- Day Lewis Medical Croydon
- Waymade London
- Zentiva Pharma London
- Brown & Burk Hounslow West
- Aristo Pharma Ely
- Eramol Sevenoaks
- Thornton & Ross Linthwaite
- Roma Pharmaceuticals Burton upon Trent
- Resolution Chemicals London
- Drugsrus Northwood
- Thea Pharmaceuticals Newcastle under Lyme
- Aventis Pharma Reading
- Fontus Health Walsall
Description
Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1 Offer reference number: CM/PHG/22/5666 FIND A TENDER (FTS) Reference number: 2023/S 000-000801 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. CM/PHG/22/5666/00 - Transition Products: CESW 01/08/2023 - 31/01/2024 (6 months) NWLN 01/08/2023 - 31/01/2025 (18 months) LSNE 01/08/2023 - 31/05/2024 (10 months) CM/PHG/22/5666/01 - Orals (plus non-parenteral) Products: All regions: 01/08/2023 to 31/05/2024 (10 Months)
Award Detail
1 | Ipca Laboratories (Sunderland)
|
2 | Drreddys Laboratories (Milton)
|
3 | Relonchem (Widnes)
|
4 | Milpharm (South Ruislip)
|
5 | Sandoz (Camberley)
|
6 | Teva (Castleford)
|
7 | Amarox (Ely)
|
8 | Accord (Barnstable)
|
9 | Strandhaven (Ilford)
|
10 | Tillomed Laboratories (Luton)
|
11 | Wockhardt (Wrexham)
|
12 | Neuraxpharm (Cardiff)
|
13 | Medac Pharma (Stirling)
|
14 | Syri (Ruislip)
|
15 | Sun Pharma (Uxbridge)
|
16 | Crescent Pharma (Basingstoke)
|
17 | Consilient Health (Richmond upon Thames)
|
18 | Day Lewis Medical (Croydon)
|
19 | Waymade (London)
|
20 | Zentiva Pharma (London)
|
21 | Brown & Burk (Hounslow West)
|
22 | Aristo Pharma (Ely)
|
23 | Eramol (Sevenoaks)
|
24 | Thornton & Ross (Linthwaite)
|
25 | Roma Pharmaceuticals (Burton upon Trent)
|
26 | Resolution Chemicals (London)
|
27 | Drugsrus (Northwood)
|
28 | Thea Pharmaceuticals (Newcastle under Lyme)
|
29 | Aventis Pharma (Reading)
|
30 | Fontus Health (Walsall)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract is suitable for SMEs.
Other Information
CM_PHG_22_5666_01 Transition 2023_1 Transparancy Award Schedules CM_PHG_22_5666_01 Transition 2023_1 Transparancy Award Schedules.pdf CM_PHG_22_5666_00 Transition 2023_1 Transparency Award Schedules CM_PHG_22_5666_00 Transition 2023_1 Transparency Award Schedules.pdf
Reference
- CF-1587300D0O000000rwimUAA
- CF 82b7505c-e6e7-47d8-bb19-a1290cc3a40d